D-Wave Quantum: The Order Book Is Exploding, But the Income Statement Hasn't Caught Up

D-Wave's Q2 revenue misses estimates, but bookings surge 1,120% and a Nature milestone fuels an 8.5% stock rally.

For a company whose stock trades on the whims of quantum breakthroughs and quarterly scorecards, D-Wave Quantum has spent the past week embodying two entirely different narratives at once. On August 5, the company announced a peer-reviewed error-correction milestone in Nature. Twenty-four hours later, it posted second-quarter numbers that missed every major Wall Street estimate. The market's response? A shrug — and then a 8.5% rally over the following week.

That contradiction is the whole story in miniature. Investors are being asked to weigh a technology story that keeps delivering against a commercial reality that keeps lagging behind.

The Q2 Scorecard: Misses Across the Board

Revenue for the quarter came in at $3.07 million, well shy of the $4.03 million consensus. The per-share loss of -$0.13 was also steeper than the -$0.09 analysts had penciled in, and gross margin slipped from 63.8% to 55.4%. On the surface, that's a company struggling to monetize what it builds — a roughly 24% revenue shortfall is not a rounding error at a valuation like this one.

But the bookings line tells a different story. First-half bookings jumped 1,120% year over year to $35.5 million, while remaining performance obligations (RPO) climbed 668% to $40.7 million. The GAAP net loss also narrowed dramatically, from $167.3 million to $48.0 million. When customers are signing contracts today that only convert to revenue in future periods, any single quarter's top line says more about timing than demand.

The company is also sitting on $546.2 million in cash, giving it ample runway to keep that bet alive without near-term financing pressure.

Deals Are Landing, Even If Revenue Isn't

The disconnect between contract signing and revenue recognition is practically a business model at this point. Roughly two weeks ago, an expanded partnership with AT&T provided a catalyst — the stock has gained 16.0% since. Early August brought a multi-year agreement with Nasdaq Verafin to build a proof-of-concept for quantum-hybrid applications in financial crime detection, including money laundering and fraud screening. Days earlier, the National Research Council of Canada approved up to CAD 300,000 in funding for annealing-based quantum software development.

None of these agreements show up meaningfully on the income statement yet. But they signal something important: D-Wave is selling into industries that depend on hard optimization problems — finance, logistics, security.

The company itself expects to close two major quantum system sales in the fourth quarter, deals it considers crucial to hitting its annual revenue targets. Until then, the gap between the order book and the P&L remains an open question.

The Technology Pipeline: Annealing Funds the Future

While the existing annealing business generates the cash flow, D-Wave is pushing hard on its next generation of technology. The Nature paper published in early August detailed a fast, high-precision two-qubit gate for its dual-rail architecture using superconducting qubits — a critical building block toward fault-tolerant gate-model quantum computing.

It's a familiar pattern from the semiconductor industry: an established technology funds research into the next one. At D-Wave, annealing is the revenue anchor for the far more expensive gate-model bet.

The government is now a stakeholder in that wager. The U.S. Department of Commerce holds an equity stake in D-Wave after a $100 million CHIPS Act funding agreement was finalized. When Washington trades equity for grant money, it's a signal that quantum computing is being treated as strategically important — regardless of how volatile the stock price gets on a daily basis.

Analysts Hold the Line, Insiders Don't

Despite the missed quarter, the analyst community has barely budged. The consensus rating remains Strong Buy to Moderate Buy, with a price target of roughly $34.67 across 16 analysts — implying substantial upside from current levels. Wedbush sees $40, Rosenblatt goes further at $43.

Those firms are clearly weighting the error-correction breakthrough and bookings growth more heavily than the near-term revenue miss. That's defensible, but it's a bet, not a fact: targets of that magnitude assume the order momentum eventually converts into revenue.

Meanwhile, there's a counter-signal worth paying attention to. Insiders have sold roughly $35.8 million worth of stock over the past three months, including CEO Alan Baratz's June sale of 687,627 shares at $26.13. The Royal Bank of Canada also trimmed its position by nearly 20% in the first quarter, down to about 240,749 shares.

Insider selling isn't automatically a red flag — diversification and tax planning are common reasons. But when management and institutional holders are both taking money off the table while analysts call for targets far above the current price, that tension deserves attention rather than dismissal.

Where the Stock Stands

The shares closed Friday at €18.30, just below the 50-day moving average of €18.36 — a sign the market has largely digested the earnings disappointment. The stock is up 1.0% on the day and 15% over the past 30 days, but still down 19% year to date. It has recovered 64% from its 52-week low of €11.12 in late March, yet remains 55% below its October high of €40.41.

That range tells its own story: the market is pricing neither the euphoria of the peak nor the panic of the trough, but a corridor of uncertainty. Progress is being priced in waves, not in a straight line.

The real question for investors isn't whether D-Wave will deliver the next headline-grabbing announcement — it has shown it can do that on a regular basis. The question is whether bookings, research breakthroughs, and government backing can translate into revenue fast enough to justify a market capitalization of roughly €6.7 billion. With the two system sales promised for Q4, that's a bill that comes due soon enough.